← Back to Search

Healthy Control Cohort for Lung Cancer

N/A
Recruiting
Research Sponsored by Nucleix Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

Study Summary

This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance

Trial Design

3Treatment groups
Experimental Treatment
Group I: USPSTF At Risk - Control CohortExperimental Treatment1 Intervention
Healthy subjects aged 50-80 years old with smoking history of at least 20 pack years.
Group II: Healthy Control CohortExperimental Treatment1 Intervention
Healthy subjects aged 20-80 years old which are non-smokers or with smoking history of less than 20 pack years.
Group III: Cases CohortExperimental Treatment1 Intervention
Subjects age 50-80 years old, with smoking history of at least 20 pack years with either (a) a high suspicion for lung cancer, who are planned to undergo biopsy or surgery to establish a definitive diagnosis after enrollment; or (b) confirmed primary lung cancer diagnosis, treatment naïve subjects.

Find a Location

Who is running the clinical trial?

Nucleix Ltd.Lead Sponsor
8 Previous Clinical Trials
8,581 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2791 spots leftby Dec 2025